Jessica Perez, a mom of seven from Belton, is fighting to regain her strength after being diagnosed with Guillain-Barré ...

Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...

Not all Guillain-Barré cases are associated with infection, and studies have suggested a link between the rare disorder and certain cancers, including lymphomas. Certain cancers, such as lymphomas, ...

Previously we have discussed neuropathy in the context of diabetic neuropathy, back-related neuropathies and the like. However, this week we are going to discuss an autoimmune neuropathy called ...

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in their 60s ...

HOUSTON, Texas (KTRK) -- A Houston woman spent 22 days in the hospital suffering from a rare disorder known as Guillain-Barré that she said her doctor determined was brought on by her COVID-19 vaccine ...

A new Guillain-Barré syndrome mimic that appeared to be triggered by mild infection emerged in children with biallelic RCC1 variants, a case series showed. One of the first cases was seen in a ...

As more U.S. adults get their Covid-19 vaccines, a variety of side effects are emerging. WSJ’s Daniela Hernandez speaks with an infectious disease specialist on what is common, what isn’t and when to ...

FRESNO, Calif. (KFSN) -- Turning pain into action. It's been eight years since Rob Vasquez was diagnosed with Guillain-Barré Syndrome. "It's been a long journey," said Cheryl Vasquez, Rob's wife. "For ...

A 25-year-old Italian woman has found herself slowly being paralyzed by a rare disease. Initially experiencing back pain, Aurora Mattei's facial muscles and body became paralyzed over the course of ...

KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...